CDKN2A and myotonic dystrophy type 1: The increased expression is also supported by results from muscle and brain samples from DM1 samples obtained from RNA-Seq data sets previously published from other research groups (54, 55), where p21CIP expression is elevated but not CDKN2A or p27KIP in DM1 samples (Figure 9, C and D).